These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3509364)

  • 1. In vitro activity of aztreonam against Pseudomonas: epidemiological aspects.
    Crotti D; Barbieri C; Cellie P; Fonzo G; Visintin F
    Chemioterapia; 1987 Jun; 6(2 Suppl):107-8. PubMed ID: 3509364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro effects of aztreonam against Pseudomonas aeruginosa].
    Marone P; Concia E; Perversi L; Monzillo V; Cruciani M
    G Ital Chemioter; 1985; 32(2):411-4. PubMed ID: 3938743
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro antibacterial activity of aminoglycoside antibiotics against Pseudomonas strains.
    Panse MV; Nair KR
    Hindustan Antibiot Bull; 1981; 23():30-2. PubMed ID: 7309552
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pseudomonas: microbiological aspects and sensitivity to tobramycin and gentamycin].
    Ceruti T; Bassi L; Biazzi E; Fasani AM; Pedroni P
    Arch Sci Med (Torino); 1982; 139(4):463-5. PubMed ID: 6820271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?].
    Torné J; García Flores A; Tomás S; Serrano R
    Med Clin (Barc); 1987 Oct; 89(13):572. PubMed ID: 3121961
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests].
    Pérez Ureña MT; Iriarte MT; Fernández P
    Rev Clin Esp; 1969 May; 113(3):235-40. PubMed ID: 5348710
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pseudomonas pyocyanea: in-vitro sensitivity to antibiotics].
    Cucchiara E
    G Mal Infett Parassit; 1971 Nov; 23(11):1045-7. PubMed ID: 5150979
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

  • 12. Current therapies for pseudomonas aeruginosa.
    Giamarellou H; Kanellakopoulou K
    Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
    Fodor E; Hajdú E; Nagy E
    Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pseudomonas maltophilia infections].
    Pintér M; Kántor M
    Orv Hetil; 1974 Feb; 115(5):254-5. PubMed ID: 4839507
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of teicoplanin and imipenem on respiratory infections in high risk patients.
    Piu G; Aresu G; Pautasso M; Garau G; Melis S; Ceccio S; Morini M; Palomba A
    J Chemother; 1991 Jan; 3 Suppl 1():222-3. PubMed ID: 12041770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we be afraid of the Green Monster?
    Rumbaugh K
    Crit Care Med; 2009 May; 37(5):1826-7. PubMed ID: 19373066
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hospitalism in urology].
    Lipsky H
    Med Klin; 1970 Oct; 65(42):1833-8. PubMed ID: 4997048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.